Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Saad A. W. Shakir"'
Autor:
Vicki Osborne, Saad A. W. Shakir
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/4e9f042b601a49bdb8addea21510af81
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/
Externí odkaz:
https://doaj.org/article/1bc2f40acf624ee4b931cdecd2583bee
Publikováno v:
Drug Safety
Osborne, V, Lane, S L & Shakir, S A W 2021, ' The role of the contextual cohort to resolve some challenges and limitations of comparisons in pharmacoepidemiology ', Drug Safety . https://doi.org/10.1007/s40264-021-01074-y
Osborne, V, Lane, S L & Shakir, S A W 2021, ' The role of the contextual cohort to resolve some challenges and limitations of comparisons in pharmacoepidemiology ', Drug Safety . https://doi.org/10.1007/s40264-021-01074-y
In pharmacoepidemiology, comparison studies can provide a useful estimate of the level of increased or decreased risk of specific events with a medication (through a measure of effect). A key focus of pharmacoepidemiological studies is the safety and
Publikováno v:
Drug Safety
Drug safety, 44(1):1-5
Drug safety, 44(1):1-5
There is an urgent need for the development of a safe and effective vaccine for COVID-19. As such, COVID-19 vaccine candidates have been developed at unprecedented speed, and there are currently a handful of vaccines in the final stages of clinical t
Publikováno v:
BMJ Evidence-Based Medicine
BackgroundPrior to approval in the European Union, a systematic benefit-risk assessment was required to compare buprenorphine implant to sublingual buprenorphine as part of the license application to the European Medicines Agency.ObjectiveThe Benefit
Autor:
Vicki Osborne, Saad A. W. Shakir
Publikováno v:
Pharmacoepidemiology
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition
Objectives: In the UK, Movicol paediatric plain (polyethylene glycol 3350 with electrolytes [PEG 3350+E], Norgine, UK), is licensed for chronic constipation in children 2 –11 years of age and faecal impaction (FI) from 5 years. This study aimed to
Publikováno v:
BMJ Evidence-Based Medicine
In the current era of the COVID-19 pandemic, the world has never been more interested in the process of vaccine development. While researchers across the globe race to find an effective yet safe vaccine to protect populations from the newly emergent
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0240489 (2020)
PLoS ONE, Vol 15, Iss 10, p e0240489 (2020)
IntroductionAlthough the direct oral anticoagulant rivaroxaban is recommended for stroke prevention in patients with non-valvular atrial fibrillation based on Phase III clinical trials, there is still a need for additional safety data from everyday c
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Therapeutic Advances in Psychopharmacology
Therapeutic Advances in Psychopharmacology
Background: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/